Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 1,215 shares at $13.80 ($17K) on 2020-01-06, disclosed to the SEC on 2020-01-06.
Scheduled sale ($17k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.08 | 700 | $10K | 58.1% |
| 2 | $13.80 | 515 | $7K | 41.9% |
| Total | $13.96 avg | 1,215 | $17K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |